Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 3/2014

01-04-2014 | Original Paper

Engagement in HIV Care Among HIV-Positive Men Who Have Sex with Men From 21 Cities in the United States

Authors: Gabriela Paz-Bailey, Huong Pham, Alexandra M. Oster, Amy Lansky, Trista Bingham, Ryan E. Wiegand, Elizabeth DiNenno, Jacek Skarbinski, James D. Heffelfinger

Published in: AIDS and Behavior | Special Issue 3/2014

Login to get access

Abstract

We assessed factors associated with HIV care among HIV-infected men who have sex with men (MSM). We used 2008 data on MSM from the National HIV Behavioral Surveillance System (NHBS). Venue-based, time–space sampling was used to recruit and interview men in 21 U.S. cities with high AIDS prevalence. Among self-reported HIV-positive MSM, we used generalized estimating equations (clustered on city of interview) to evaluate factors associated with delayed linkage to care (care entry >3 months after diagnosis), not currently receiving care (no visit for HIV care during the 6 months before the study interview), and not being on antiretroviral therapy (ART). Among 8,153 MSM, 882 (11 %) were self-reported HIV-positive. 25 % had delayed linkage, 12 % were not currently receiving care and among those with at least one heath care visit 30 % were not on ART. In multivariate analysis, lower income and testing positive at their first HIV test were associated with delayed linkage. Age 18–29 years, and not having health insurance were associated with not currently receiving care. Among those with at least one health care visit, being age 18–39 years, having private or no health insurance, and stimulant use were associated with not being on ART. These findings can inform efforts to improve engagement in care.
Appendix
Available only for authorised users
Literature
1.
2.
3.
4.
CDC. Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data—United States and 6 U.S. Dependent Areas, 2010. Atlanta: US Centers for Disease Control and Prevention; 2012.
5.
Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J. Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr. 2012;60:77–82.PubMedCrossRef
6.
Giordano TP, Hartman C, Gifford AL, Backus LI, Morgan RO. Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials. 2009;10:299–305.PubMedCrossRef
7.
Bamford LP, Ehrenkranz PD, Eberhart MG, Shpaner M, Brady KA. Factors associated with delayed entry into primary HIV medical care after HIV diagnosis. AIDS. 2010;24:928–30.PubMedCrossRef
8.
Mugavero MJ, Lin HY, Willig JH, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48:248–56.PubMedCentralPubMedCrossRef
9.
Hall HI, Frazier EL, Rhodes P, et al. Continuum of HIV care: differences in care and treatment by sex and race/ethnicity in the United States. XIX International AIDS Conference. Washington DC; 2012.
10.
Christopoulos KA, Das M, Colfax GN. Linkage and retention in HIV care among men who have sex with men in the United States. Clin Infect Dis. 2011;52(Suppl 2):S214–22.PubMedCentralPubMedCrossRef
11.
Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDs. 2009;23:41–9.PubMedCentralPubMedCrossRef
12.
Reed JB, Hanson D, McNaghten AD, et al. HIV testing factors associated with delayed entry into HIV medical care among HIV-infected persons from eighteen states, United States, 2000–2004. AIDS Patient Care STDs. 2009;23:765–73.PubMedCrossRef
13.
14.
Gallagher KM, Sullivan PS, Lansky A, Onorato IM. Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System. Public Health Rep. 2007;122(Suppl 1):32–8.PubMedCentralPubMed
15.
Finlayson TJ, Le B, Smith A, et al. HIV risk, prevention, and testing behaviors among men who have sex with men—National HIV Behavioral Surveillance System, 21 U.S. cities, United States, 2008. MMWR Surveill Summ. 2011;60:1–34.PubMed
16.
Sanchez T, Finlayson T, Drake A, et al. Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors–United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003–April 2005. MMWR Surveill Summ. 2006;55:1–16.PubMed
17.
CDC. Prevalence and awareness of HIV infection among men who have sex with men—21 cities, United States, 2008. MMWR Morb Mortal Wkly Rep. 2010;59:1201–7.
18.
MacKellar DA, Gallagher KM, Finlayson T, Sanchez T, Lansky A, Sullivan PS. Surveillance of HIV risk and prevention behaviors of men who have sex with men: a national application of venue-based, time–space sampling. Public Health Rep. 2007;122(Suppl 1):39–47.PubMedCentralPubMed
19.
Allen DR, Finlayson T, Abdul-Quader A, Lansky A. The role of formative research in the National HIV Behavioral Surveillance System. Public Health Rep. 2009;124:26–33.PubMedCentralPubMed
20.
Mugavero MJ, Davila JA, Nevin CR, Giordano TP. From access to engagement: measuring retention in outpatient HIV clinical care. AIDS Patient Care STDs. 2010;24:607–13.PubMedCentralPubMedCrossRef
21.
Mancl LA, DeRouen TA. A covariance estimator for GEE with improved small-sample properties. Biometrics. 2001;57:126–34.PubMedCrossRef
22.
SAS Institute Inc. SAS/STAT 9.2 User’s Guide: SAS Institute Inc., Cary, NC, USA; 2008.
23.
Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793–800.PubMedCentralPubMedCrossRef
24.
Kalichman SC, Schaper PE, Belcher L, et al. It’s like a regular part of gay life: repeat HIV antibody testing among gay and bisexual men. AIDS Educ Prev. 1997;9:41–51.PubMed
25.
Girardi E, Aloisi MS, Arici C, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr. 2004;36:951–9.PubMedCrossRef
26.
27.
Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008;300:555–70.PubMedCrossRef
28.
Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308:387–402.PubMed
29.
30.
31.
32.
Lillie-Blanton M, Stone VE. Snow Jones A, et al. Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005. Am J Public Health. 2010;100:1493–9.PubMedCentralPubMedCrossRef
33.
Kahn JG, Haile B, Kates J, Chang S. Health and federal budgetary effects of increasing access to antiretroviral medications for HIV by expanding Medicaid. Am J Public Health. 2001;91:1464–73.PubMedCentralPubMedCrossRef
34.
Keruly JC, Conviser R, Moore RD. Association of medical insurance and other factors with receipt of antiretroviral therapy. Am J Public Health. 2002;92:852–7.PubMedCentralPubMedCrossRef
35.
Cunningham WE, Markson LE, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. HCSUS Consortium. HIV Cost and Services Utilization. J Acquir Immune Defic Syndr. 2000;25:115–23.PubMedCrossRef
36.
Fleishman JA, Yehia BR, Moore RD, Korthuis PT, Gebo KA, Network HIVR. Establishment, retention, and loss to follow-up in outpatient HIV care. J Acquir Immune Defic Syndr. 2012;60:249–59.PubMedCentralPubMedCrossRef
37.
38.
Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301:2380–2.PubMedCrossRef
39.
Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–57.PubMedCrossRef
40.
Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006;368:531–6.PubMedCrossRef
41.
Grossman CI, Forsyth A, Purcell DW, Allison S, Toledo C, Gordon CM. Advancing novel HIV prevention intervention research with MSM: meeting report. Public Health Rep. 2011;126:472–9.PubMedCentralPubMed
Metadata
Title
Engagement in HIV Care Among HIV-Positive Men Who Have Sex with Men From 21 Cities in the United States
Authors
Gabriela Paz-Bailey
Huong Pham
Alexandra M. Oster
Amy Lansky
Trista Bingham
Ryan E. Wiegand
Elizabeth DiNenno
Jacek Skarbinski
James D. Heffelfinger
Publication date
01-04-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 3/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0605-y

Other articles of this Special Issue 3/2014

AIDS and Behavior 3/2014 Go to the issue

Original Paper

Using Baltimore HIV Behavioral Surveillance Data for Local HIV Prevention Planning

Original Paper

Trends in HIV Prevalence and HIV Testing Among Young MSM: Five United States Cities, 1994–2011

Original Paper

Comparison of Surveillance Sample Demographics Over Two Cycles of the National HIV Behavioral Surveillance Project, Houston, Texas

Original Paper

Prevalence of HIV Infection and Risk Behaviors Among Younger and Older Injecting Drug Users in the United States, 2009

Original Paper

HIV Testing Among Heterosexuals at Elevated Risk for HIV in the District of Columbia: Has Anything Changed Over Time?

Original Paper

Comparing Study Populations of Men Who Have Sex with Men: Evaluating Consistency Within Repeat Studies and Across Studies in the Seattle Area Using Different Recruitment Methodologies
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits